Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for subcutaneous amivantamab and hyaluronidase-lpuj as ...
MTX240's mechanistic novelty may give it a long-awaited edge in treatments for gastrointestinal stromal tumors (GIST)Meg Flippin, Benzinga Staff Writer CARDIFF, UK / ACCESS Newswire / February 19, ...
MTX240's mechanistic novelty may give it a long-awaited edge in treatments for gastrointestinal stromal tumors (GIST)Meg Flippin, Benzinga Staff Writer CARDIFF, UK / ACCESS Newswire / February 19, 202 ...
Jim Tananbaum, MD, Foresite Capital’s founder and CEO, and Michael Rome, PhD, the managing director who leads the firm’s therapeutics investing practice, discuss the firm’s approach to nurturing ...
Allied Market Research published a report, titled, "Astaxanthin Market by Source (Natural and Synthetic), Form (Dry and Liquid), and Application (Dietary supplements, Cosmetics and Others): Global ...
Studies show that about half of surrendered dogs are adolescents, explains Christopher Pachel, DVM, DACVB, CABC (IAABC).
Myopia is skyrocketing around the world, often blamed on endless screen time — but new research suggests the real culprit may be something more subtle. Scientists at SUNY College of Optometry propose ...
The perception of faces where none exist can be a window into how the brain makes sense of the world. This phenomenon, known as pareidolia, reveals the fundamental architecture of visual cognition: a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results